Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Production of hiPSC-based tumour models

ABSTRACT: Production of hiPSC-based tumour models

PROVIDER: PRJNA777945 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR16775631_1.fastq.gz	Fastqsanger.gz
	SRR16775631_2.fastq.gz	Fastqsanger.gz
	SRR16775632_1.fastq.gz	Fastqsanger.gz
	SRR16775632_2.fastq.gz	Fastqsanger.gz
	SRR16775633_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 54

Similar Datasets

Epigenome analysis of hiPSC-based tumour models II

Project description:Epigenome analysis of hiPSC-based tumour models II

| PRJNA777943 | ENA

Epigenome analysis of hiPSC-based tumour models I

Project description:Epigenome analysis of hiPSC-based tumour models I

| PRJNA777944 | ENA

Production of hiPSC-based tumour models

Project description:Generation of in vitro models of cancer stem cells for in vivo xenograft models. hiPSC differentiation into a desired tissue allows studying physiologic processes in human-relevantcell systems. By introducing disease-specific mutations, these cells allow studying genetic origins of diseases in a tissue-specific manner.

2023-07-04 | GSE188228 | GEO

Epigenome analysis of hiPSC-based tumour models II

2023-07-04 | GSE188227 | GEO

Epigenome analysis of hiPSC-based tumour models I

2023-07-04 | GSE188226 | GEO

Single-cell RNA sequencing of human liver development and hiPSC models

Project description:scRNA-seq of primary human adult liver, primary human fetal liver (5 post conceptional weeks), EPCAM+ MACS sorted primary human intrahepatic duct cholangiocytes, sequential timepoints of hiPSC-derived hepatocyte-like cells (HLC), sequential timepoints of hiPSC-derived cholangiocyte-like cells (CLC), sequential timepoints of hiPSC-derived hepatic stellate-like cells (HSLC), sequential timepoints of hiPSC-derived endothelial-like cells (ELC), sequential timepoints of hiPSC-derived macrophage-like cells (MLC) and lentiviral transduced hiPSC-derived hepatocyte-like cells.

2022-05-04 | E-MTAB-8210 | biostudies-arrayexpress

Differential expression of murine syngeneic orthotopic glioblastoma tumour models

Project description:Bulk RNA sequencing analysis of murine syngeneic orthotopic GL261-luc2 and CT2A-luc glioblastoma tumour models

2023-11-01 | GSE215123 | GEO

Differential expression of murine syngeneic orthotopic glioblastoma tumour models

Project description:Differential expression of murine syngeneic orthotopic glioblastoma tumour models

| PRJNA888952 | ENA

Single-cell RNA sequencing of human liver development and hiPSC models

Project description:Single-cell RNA sequencing of human liver development and hiPSC models

| PRJEB49425 | ENA

Transcriptional signatures of schizophrenia in hiPSC-derived NPCs and neurons are concordant with signatures from post mortem adult brains

Project description:Whereas highly penetrant variants have proven well-suited to human induced pluripotent stem cell (hiPSC)-based models, the power of hiPSC-based studies to resolve the much smaller effects of common variants within the size of cohorts that can be realistically assembled remains uncertain. In developing a large case/control schizophrenia (SZ) hiPSC-derived cohort of neural progenitor cells and neurons, we identified and accounted for a variety of technical and biological sources of variation. Reducing the stochastic effects of the differentiation process by correcting for cell type composition boosted the SZ signal in hiPSC-based models and increased the concordance with post mortem datasets. Because this concordance was strongest in hiPSC-neurons, it suggests that this cell type may better model genetic risk for SZ. We predict a growing convergence between hiPSC and post mortem studies as both approaches expand to larger cohort sizes. For studies of complex genetic disorders, to maximize the power of hiPSC cohorts currently feasible, in most cases and whenever possible, we recommend expanding the number of individuals even at the expense of the number of replicate hiPSC clones.

2018-02-23 | GSE106589 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data